ES2167608T3 - Composicion basada en monoxido de nitrogeno como medicamento. - Google Patents

Composicion basada en monoxido de nitrogeno como medicamento.

Info

Publication number
ES2167608T3
ES2167608T3 ES96934916T ES96934916T ES2167608T3 ES 2167608 T3 ES2167608 T3 ES 2167608T3 ES 96934916 T ES96934916 T ES 96934916T ES 96934916 T ES96934916 T ES 96934916T ES 2167608 T3 ES2167608 T3 ES 2167608T3
Authority
ES
Spain
Prior art keywords
pct
nitrogen monoxide
composition based
medicinal product
date
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96934916T
Other languages
English (en)
Inventor
Robert Briend
Marie-Helene Renaudin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LAir Liquide SA pour lEtude et lExploitation des Procedes Georges Claude
Original Assignee
LAir Liquide SA a Directoire et Conseil de Surveillance pour lEtude et lExploitation des Procedes Georges Claude
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LAir Liquide SA a Directoire et Conseil de Surveillance pour lEtude et lExploitation des Procedes Georges Claude filed Critical LAir Liquide SA a Directoire et Conseil de Surveillance pour lEtude et lExploitation des Procedes Georges Claude
Application granted granted Critical
Publication of ES2167608T3 publication Critical patent/ES2167608T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LA INVENCION ESTA RELACIONADA CON LA UTILIZACION DE UNA COMPOSICION GASEOSA QUE CONTIENE MONOXIDO DE NITROGENO (NO) Y DIOXIDO DE CARBONO (CO 2 ) PARA FABRICAR UN MEDICAMENTO GAS EOSO DESTINADO A TRATAR Y/O PREVENIR POR VIA INTRAVASCULAR LA ISQUEMIA.
ES96934916T 1995-10-20 1996-10-15 Composicion basada en monoxido de nitrogeno como medicamento. Expired - Lifetime ES2167608T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9512345 1995-10-20

Publications (1)

Publication Number Publication Date
ES2167608T3 true ES2167608T3 (es) 2002-05-16

Family

ID=9483741

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96934916T Expired - Lifetime ES2167608T3 (es) 1995-10-20 1996-10-15 Composicion basada en monoxido de nitrogeno como medicamento.

Country Status (9)

Country Link
US (2) US6051241A (es)
EP (2) EP0855912B1 (es)
JP (2) JPH11513703A (es)
AT (1) ATE209922T1 (es)
AU (2) AU701760B2 (es)
CA (1) CA2188238A1 (es)
DE (1) DE69617719D1 (es)
ES (1) ES2167608T3 (es)
WO (2) WO1997015311A1 (es)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6106497A (en) * 1997-01-31 2000-08-22 Medical Instrument Development Laboratories System and method for preventing an air embolism in a surgical procedure
EP0887076A3 (en) 1997-05-07 1999-03-31 Saturnus A.G. Adhesion prevention and an endoscopic insufflation system therefor
US6660301B1 (en) * 1998-03-06 2003-12-09 Biosphere Medical, Inc. Injectable microspheres for dermal augmentation and tissue bulking
FR2775967B1 (fr) * 1998-03-10 2000-06-23 Air Liquide Melange gazeux conditionne supercritique contenant du co2, du no et eventuellement du gaz neutre
DE19833014A1 (de) * 1998-07-23 2000-01-27 Messer Griesheim Gmbh Edelgashaltige Injektionsanästhesiemittel
US6503740B1 (en) 2000-02-22 2003-01-07 Biomin, Inc. Organically modified mineral materials containing engrafted bacteria for chemical contaminant decomposition
WO2001070289A2 (en) 2000-03-20 2001-09-27 Biosphere Medical, Inc. Injectable and swellable microspheres for tissue bulking
US6676855B2 (en) * 2001-08-02 2004-01-13 Duke University Use of a blood-flow decrease preventing agent in conjunction with insufflating gas
US20040225275A1 (en) * 2001-08-02 2004-11-11 Reynolds James Dixon Fetal physiology during maternal surgery or diagnosis
US20050244508A1 (en) * 2002-06-12 2005-11-03 Messer Griesheim Anti-spasmodic comprising xenon
JP2005533062A (ja) * 2002-06-12 2005-11-04 メツサー グリースハイム ゲゼルシヤフト ミツト ベシユレンクテル ハフツング キセノン含有ガスによる脳保護
WO2004004782A1 (de) * 2002-07-05 2004-01-15 Messer Griesheim Gmbh Xenon enthaltendes adjuvans
DE10336768B4 (de) * 2002-08-10 2010-09-09 Air Liquide Deutschland Gmbh Medikament zur Verbesserung der Sauerstoffutilation
EP1556121B1 (en) 2002-10-28 2016-06-01 Northgate Technologies Incorporated Insufflation system with a multi-capacity tube
US7654975B2 (en) * 2003-04-24 2010-02-02 Northgate Technologies, Inc. Mixed-gas insufflation system
DE202004021703U1 (de) * 2003-10-07 2010-05-27 Northgate Technologies Inc., Elgin Vorrichtung zur Abgabe einer Substanz in eine Körperhöhle
CA2543680C (en) * 2003-10-31 2012-05-22 Trudell Medical International System and method for manipulating a catheter for delivering a substance to a body cavity
CN100475275C (zh) * 2004-01-05 2009-04-08 董永华 肿瘤血管栓塞剂及其储存和释放装置
SE0402221D0 (sv) 2004-09-14 2004-09-14 Aerocrine Ab Treatment of insufficient perfusion
US9358193B2 (en) * 2005-02-15 2016-06-07 Martin S. Giniger Whitening compositions and methods involving nitrogen oxide radicals
ES2666919T3 (es) * 2006-08-04 2018-05-08 Northgate Technologies, Inc. Puerto permanente para acceso a un cuerpo
JP5581500B2 (ja) 2010-03-10 2014-09-03 学校法人北里研究所 虚血再灌流障害軽減用治療剤および治療装置
US11439309B2 (en) 2011-05-05 2022-09-13 Cedars-Sinai Medical Center Assessment of coronary heart disease with carbon dioxide
US11129911B2 (en) 2011-05-05 2021-09-28 Cedars-Sinai Medical Center Assessment of coronary heart disease with carbon dioxide
CN103565745A (zh) 2012-08-10 2014-02-12 德克萨斯州大学系统董事会 用于治疗中风的神经保护性脂质体组合物和方法
CA3132914C (en) 2013-03-15 2023-11-07 The Board Of Regents Of The University Of Texas System Liquids rich in noble gas and methods of their preparation and use
US9517318B2 (en) 2013-06-28 2016-12-13 L'Air Liquide, Société Anonyme pour l'Etude et l'Exploitation des Procédés Georges Claude Method of delivering medical gases via a nasal cannula assembly with flow control passage communicating with a deformable reservoir
US9522248B2 (en) 2013-06-28 2016-12-20 L'Air Liquide, Société Anonyme pour l'Etude et l'Exploitation des Procédés Georges Claude Breathing assistance apparatus for delivery of nitric oxide to a patient by means of a nasal cannula assembly with flow control passage
US9566407B2 (en) 2013-06-28 2017-02-14 L'Air Liquide, Société Anonyme pour l'Etude et l'Exploitation des Procédés Georges Claude Nasal cannula assembly with flow control passage communicating with a deformable reservoir
US9486600B2 (en) 2013-06-28 2016-11-08 L'Air Liquide, Société Anonyme pour l'Etude et l'Exploitation des Procédés Georges Claude Nasal cannula assembly with inhalation valves communicating with a deformable reservoir
US9522247B2 (en) 2013-06-28 2016-12-20 L'Air Liquide, Société Anonyme pour l'Etude et l'Exploitation des Procédés Georges Claude Method of treating a patient having pulmonary hypertension by long term NO therapy
US9492626B2 (en) 2013-06-28 2016-11-15 L'Air Liquide, Société Anonyme pour l'Etude et l'Exploitation des Procédés Georges Claude Breathing assistance assemblies suitable for long term no therapy
WO2015021078A1 (en) 2013-08-05 2015-02-12 Cedars-Sinai Medical Center Methods for reducing ischemia-reperfusion injury
US9572595B1 (en) 2014-03-05 2017-02-21 Northgate Technologies Inc. In-dwelling port for access into a body
GB2579240B (en) 2018-11-27 2020-12-16 Attgeno Ab New processes, compositions and medical uses
GB202007929D0 (en) 2020-05-27 2020-07-08 Attgeno Ab New medical uses
CN111840583B (zh) * 2020-08-06 2023-03-28 温州医科大学 血管内皮损伤治疗的药物制剂

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5443826A (en) * 1988-08-02 1995-08-22 Borody; Thomas J. Treatment of gastro-intestinal disorders with a fecal composition or a composition of bacteroides and E. Coli
WO1992010228A1 (en) * 1990-12-05 1992-06-25 The General Hospital Corporation Devices for treating pulmonary vasoconstriction and asthma
US5536241A (en) * 1990-12-05 1996-07-16 The General Hospital Corporation Methods and devices for relaxing smooth muscle contractions
US5427797A (en) * 1993-04-06 1995-06-27 Brigham And Women's Hospital Systemic effects of nitric oxide inhalation

Also Published As

Publication number Publication date
AU7305196A (en) 1997-05-15
AU7305896A (en) 1997-05-15
EP0855912B1 (fr) 2001-12-05
EP0855912A1 (fr) 1998-08-05
WO1997015311A1 (fr) 1997-05-01
JPH11513705A (ja) 1999-11-24
CA2188238A1 (fr) 1997-04-21
ATE209922T1 (de) 2001-12-15
US5670177A (en) 1997-09-23
US6051241A (en) 2000-04-18
WO1997015312A1 (fr) 1997-05-01
EP0859620A1 (fr) 1998-08-26
JPH11513703A (ja) 1999-11-24
AU701760B2 (en) 1999-02-04
DE69617719D1 (de) 2002-01-17

Similar Documents

Publication Publication Date Title
ES2167608T3 (es) Composicion basada en monoxido de nitrogeno como medicamento.
HUT77380A (hu) Kombinált gyógyszerkészítmény alkalmazása sclerosis multiplex (MS) és más demielizáló állapotok kezelésére
HUP9902105A2 (hu) Angiosztatikus dipeptideket tartalmazó gyógyászati készítmények és ezek alkalmazása
GEP20002300B (en) Purified Forms of Dnase, Method for Its Production, Pharmaceutical Composition and Use Thereof
DE69434149D1 (de) Verwendung von dhea oder dessen derivate zur herstellung eines medikaments zur vorbeugung von progressiver gewebe-nekrose, reperfusionsschädigung, bakterieller translokation und vom atemnotsyndrom bei erwachsenen
DE3876877D1 (de) Verwendung von indolon-derivaten zur herstellung von arzneimitteln zur behandlung des parkinsonismus.
BG104727A (en) Pharmaceutical composition of topiramate
KR950703968A (ko) 외상 손상과 관련된 신경학적 병변의 치료에서 카르바마제핀 및 옥스카르바제핀의 적용(application of carbamazepine and oxcarbazepine in the treatment of neurological lesions related to traumatic injuries)
MX9709977A (es) Compuestos de (acido sulfinico, acido sulfonico, sulfonilamino o sulfinilamino) n-[(aminoiminometil) fenilalquil] azaheterociclilamida sustituidos.
PL318172A1 (en) Novel analgesic pharmaceutic preparation
ATE205086T1 (de) Verwendung von dem chelatbildner clioquinol zur herstellung eines arzneimittelszur behandlung von alzheimerschen krankheit
PT998287E (pt) Utilizacao de levobupivacaina
DE69713620D1 (de) Verwendung von arachidonsäure und/oder docohexaensäure zur herstellung eines arzneimittels zur behandlung von dyspraxia
ATE205712T1 (de) Verwendung von 2-phenyl-3-aroylbenzothiophen derivaten zur herstellung eines medikaments zur hemmung der angiogenese und angiogene krankheiten
CA2274686A1 (en) Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds
MX9805705A (es) Compuestos biaromaticos, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
PL320687A1 (en) Use of incense for treating alzheimer disease
ES2160643T3 (es) Composiciones que contienen g-csf y proteina de union al tnf.
EP1086099A4 (en) COMPOUNDS BASED ON SULFONIC ACID OR SULFONYLAMINO N- (HETEROARALKYL) -AZAHETEROCYCLYLAMIDE
Alon et al. Double-blind study of the reversal of midazolam-supplemented general anaesthesia with Ro 15–1788
TR200101163T2 (tr) Safra suyu ikameli fenil-alkenoilguanidinler, üretim yöntemleri, kullanımları
FR2713640B1 (fr) Nouveaux composés aromatiques polycycliques, compositions pharmaceutiques et cosmétiques les contenant et utilisations.
DE69111974D1 (de) Verwendung von Lithium zur Behandlung oder Prophylaxe von Molluscum contagiusum.
ATE85334T1 (de) Bisphenylalkylpiperazin-derivate, verfahren zur herstellung und arzneimittelzubereitung.
AU5818394A (en) Use of prodelphinidines for treating arthrosis